ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunosuppression"

  • 2016 American Transplant Congress

    Graft Survival of Steroid-Avoidance Protocols in Pediatric Kidney Transplantation[mdash]A Propensity Score Analysis.

    E. Nehus,1 Y. Wang,2 B. Lu,3 C. Liu,2 M. Macaluso,2 M.-O. Kim.2

    1Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; 2Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; 3Division of Biostatistics, The Ohio State University, Columbus, OH.

    Purpose: This study investigated whether steroid avoidance-protocols adversely influence allograft survival among pediatric kidney transplant recipients at high levels of immunologic risk.Methods: A retrospective cohort…
  • 2016 American Transplant Congress

    Peritransplant Costimulation Blockade Combined with a Short-Course of Rapamycin Prevents Rejection of Vascularized Composite Allografts.

    B. Oh, G. Furtmüller, M. Fryer, P. Akre, D. Cooney, W. Lee, G. Raimondi, G. Brandacher.

    Department of Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

    [Background] Reconstructive transplantation represents a valid therapeutic option after devastating tissue loss. Routine clinical application, however, is hampered by the toxicity of long-term maintenance immunosuppression.…
  • 2016 American Transplant Congress

    Heat Shock Protein 90 Inhibitor 17DMAG Is a Potential New Therapeutic Agent Against Acute Allograft Rejection.

    T. Maehana,1 T. Tanaka,1 H. Kitamura,2 N. Masumori.1

    1Urology, Sapporo Medical University School of Medicine, Sapporo, Japan; 2Urology, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama, Japan.

    Purpose: We have previously demonstrated that Heat shock protein 90 (HSP90) plays a role in the development of acute rejection (AR) in organ transplantation. To…
  • 2016 American Transplant Congress

    Impact of Ethnicity on Tacrolimus Trough/Dose Ratios Following Solid Organ Transplantation.

    A. Santeusanio, A. Owusu-Obeng, J. Jeff.

    Mount Sinai Hospital, New York.

    Objective: to assess tacrolimus dosing requirements based upon ethnicity in order to help guide future decisions regarding dosage initiation and titration among Hispanic and African…
  • 2016 American Transplant Congress

    Effect of Early Tacrolimus Trough Variability on Graft Outcomes in Lung Transplantation.

    K. Boyle, M. Moranville, P. Shah.

    The Johns Hopkins Hospital, Baltimore, MD.

    Background: Recent data suggests that variability in tacrolimus trough levels after lung transplant may be associated with poor long term graft outcomes. The purpose of…
  • 2016 American Transplant Congress

    Differences in Tacrolimus Troughs and Doses Between Caucasians and African Americans with Two CYP3A5 Loss-of-Function Alleles: Looking Beyond CYP3A5 Expression.

    W. Oetting,1 D. Schladt,2 W. Guan,1 R. Remmel,1 C. Dorr,2 K. Sanghavi,1 A. Matas,1 R. Mannon,3 A. Israni,2 P. Jacobson,1 For DeKAF Genomics,1 GEN-03 Investigators.1

    1University of Minnesota, Minneapolis, MN; 2Hennepin County Medical Center and Minneapolis Medical Research Foundation, Minneapolis, MN; 3University of Alabama, Birmingham, AL.

    Higher tacrolimus (TAC) dose requirements and lower TAC troughs (TT) in African Americans (AA) relative to Caucasians (CA) have been presumed to be due to…
  • 2016 American Transplant Congress

    A Change in Insulin Sensitivity and Lipid Profile in Renal Transplant Recipients Converted from Cyclosporine or Standard Release Tacrolimus to Once-Daily Prolonged Release Tacrolimus.

    Y. Jung,1 Y. Kim,1 S. Kim,1 H. Shin,1 H. Rim,1 H. Rhew.2

    1Internal Medicine, Kosin University College of Medicine, Busan, Republic of Korea; 2Urology, Kosin University College of Medicine, Busan, Republic of Korea.

    Background : New-onset diabetes after transplantation may be associated with the use of tacrolimus (Tac) causing impaired insulin release or reduced insulin sensitivity. And, dyslipidemia…
  • 2016 American Transplant Congress

    Conversion from Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Patients Who Underwent Liver Transplantation for Unresectable Hepatoblastoma – 2 Year Follow-Up.

    R. Hendrickson,1 W. Andrews,1 M. Davis,1 R. Cisneros,1 R. Fischer,2 J. Daniel.2

    1Pediatric/Transplant Surgery, Children's Mercy Hospitals and Clinics, Kansas City, MO; 2Hepatology, Children's Mercy Hospitals and Clinics, Kansas City, MO.

    Introduction: The appropriate use of Sirolimus (SRL) immunosuppression in pediatric liver transplantation has yet to be clearly defined. Even though Tacrolimus (TAC) is commonly used…
  • 2016 American Transplant Congress

    Prospective Randomized Controlled Study Evaluating the Impact of an Electronic Feedback System on Medication Adherence in Solid Organ Transplantation.

    M. Lockwood, L. Potter, B. Kane, L. Lourenco, A. Bozdin, J. Millis.

    University of Chicago Transplant Center, University of Chicago, Chicago.

    Purpose: To evaluate the impact of and electronic feedback system (EFS), SIMpill Medication Adherence System®, on medication adherence in patients who have received a solid…
  • 2016 American Transplant Congress

    Belatacept Does Not Inhibit Plasmablast Formation Supported by Follicular T Helper Cells, but Favors the Development of Transitional Regulatory B Cells in Kidney Transplant Patients.

    G. de Graav, D. Hesselink, M. Dieterich, R. Kraaijeveld, W. Weimar, C. Baan.

    Internal Medicine, Section Transplantation and Nephrology, Erasmus University Medical Center, Rotterdam, South Holland, Netherlands.

    Since the costimulatory inhibitor belatacept effectively blocks T-B cell interaction in animal transplant models, we studied the functional follicular T helper cells (TFH)-B cell interaction…
  • « Previous Page
  • 1
  • …
  • 113
  • 114
  • 115
  • 116
  • 117
  • …
  • 138
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences